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Abstract  
Background&Aims: If are associated multiple autoimmune 
endocrine diseases, the term is polyglandular autoimmune syndrome (PAS). 
The main autoimmune polyendocrinopaties encountered are: PAS I (chronic 
mucocutaneous candidiasis, chronic autoimmune hypoparathyroidism, and 
autoimmune Addison disease), PAS II (autoimmune Addison's disease, 
autoimmune thyroid disease and/or type 1 diabetes) and PAS III 
(autoimmune thyroid disease + other autoimmune diseases). The purpose of 
this study is to determine the types of PAS in a group of children with 
thyroid diseases and diabetes mellitus (DM) type 1. 
Methods: The studied group was of 83 children with DM type 1 (71 girls 
and 12 boys), aged between 7 and 17 years. The methods of investigation 
were represented by clinical, imaging, biochemical, hormonal and 
immunological parameters. 
Results: The prevalence of PAS in the study group was: type I – 0%, type II 
- 6.02 % (80% girls and 20 % boys, p = 0.057, X2 = 3.6) and type III - 59.03 
% (85.71% girls and 14.29% boys, p < 0.001, X2 = 50). We don’t find 
significant differences between boys and girls in the case of PAS type II, but 
in type III prevailed girls, and the type was III a. 
Conclusions: The most frequent PAS was type III, subtype III a, follow by 
type II. Because Addison's disease was asymptomatic, identifying through 
the presence of specified antibodies, if we have a children with two or more 
autoimmune disease, we must investigate him for another possible 
autoimmune disease.  
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Introduction 
Type 1 diabetes is often associated with endocrine and systemic 
disease with autoimmune etiology as: Graves-Basedow disease, Hashimoto's 
thyroiditis, Addison's disease, celiac disease, pernicious anemia, myasthenia 
gravis, vitiligo, etc. (Cooper et al, 2003). 
From people with type 1 diabetes, ≈ 1 in 100 patients will develop 
Graves' disease (De Block, 2000) and ≈ 1 in 20 patients are generally 
affected by hypothyroidism (De Block, 2000). The frequency of DM type 1 
association with hyperthyroidism and hypothyroidism ranges from 3.2% to 
4.6% and from 0.7% to 4% (Radaideh et al, 2003). 
Addison’s disease is extremely rare in the general population, 
affecting ≈ 1/ 200 patients in the population with type 1 diabetes (De Block, 
2000). 
Celiac disease occurs in 1/20 patients with type 1 diabetes, pernicious 
anemia in 1/50 patients with type 1 diabetes (De Block, 2000).  
If are associated multiple autoimmune endocrine diseases, the term is 
polyglandular autoimmune syndrome (PAS). Polyglandular autoimmune 
syndromes comprise a group of autoimmune diseases characterized by 
inability of the endocrine glands to produce hormones. The endocrine 
abnormalities tend to occur together. It is estimated that about a quarter of 
patients with one gland hypofunction present another endocrine glands. It is 
therefore recommended that if is a one gland hypofunction to assess the 
function of other endocrine glands. 
There are several classifications of autoimmune polyendocrinopaties, 
but was universally accepted Neufeld and Blizzard classification: 
- PAS I - chronic mucocutaneous candidiasis, autoimmune chronic 
hypoparathyroidism,  autoimmune Addison’s disease  
- PAS II - autoimmune Addison's disease, autoimmune thyroid disease and / 
or type 1 diabetes (Addison's disease should always be present) 
- PAS III - autoimmune thyroid disease + another autoimmune diseases 
(excluding autoimmune Addison's disease, autoimmune chronic 
hypoparathyroidism, autoimmune chronic candidiasis) 
- PAS IV - 2 or more autoimmune organo-specific diseases (not covered in 
the type I, II or III). 
The most common are the PAS I, II and III. 
 
Polyglandular autoimmune syndrome type I (PAS I) usually 
begins in childhood, mucocutaneous candidiasis being usually the first 
manifestation, usually followed by hypoparathyroidism and Addison's 
disease (Aldasouqi et al, 2006, Myhre et al, 2001). Type 1 diabetes occurs in 
less than 4% of affected children, but increased to 12% in adults. 
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PAS-I is a very rare disorder. The largest number of patients was 
reported in Finland, where the prevalence was estimated at 1/25,000 
subjects. F/B ratio is 0.8 to 1.5/1; the 1998 statistical data show a ratio of 2.4 
/ 1. 
PAS - I occur in children aged 3-5 years or in early adolescence, but 
always occur through the third decade of life. Mortality and morbidity of the 
syndrome seem to be equivalent to the individual components of the 
syndrome. 
 
Type II polyglandular autoimmune syndrome (PAS II) (Betterle 
et al, 2004, Sivarajah et al, 2006) is the most common 
immunoendocrinopaty. It occurs in adulthood, affecting mostly women. 
Since most syndrome components have a long prodromal phase in which 
autoantibodies are present before developing the disease, current efforts are 
focused to establish whether immunosuppressive or immunomodulatory 
medication can prevent or stop the destructive processes. 
In the U.S. about 14 to 20 per 1 million people are affected by this 
syndrome. The F/M ratio is 3 to 4/1. PAS - II appears in the third and fourth 
decade of life. To date, PAS - II mortality and morbidity has not been 
estimated from the clinical point of view, but it is considered as equal to the 
mortality and morbidity of the individual components. 
 
Polyglandular autoimmune syndrome type III (PAS - III) (Aung 
et al, 2006) is associated with the following diseases: celiac disease, 
hypogonadism, myasthenia gravis, sarcoidosis, Sjogren's syndrome, 
rheumatoid arthritis, gastric cancer, malabsorption due to the pancreatic 
exocrine deficiency, and can be classified in three subcategories:  
- PAS III a - autoimmune thyroiditis with DM type 1 
- PAS III b - autoimmune thyroiditis with pernicious anemia 
- PAS III c - autoimmune thyroiditis with vitiligo and / or alopecia and / or 
other autoimmune diseases 
PAS III exact prevalence is unknown. PAS III is more common in 
women than in men. PAS III is typically observed in middle-aged women, 
but can occur in people of any age. Mortality and morbidity are determined 
by the individual components of the syndrome. 
Another way of classifying autoimmune polyendocrinopathies and 
associated nonendocrine systemic immunopathies was proposed by Volpe: 
- Autoimmune endocrinopathies – Graves-Basedow disease, Hashimoto's 
thyroiditis, idiopathic Addison's disease, insulin-dependent diabetes, 
autoimmune gonadal failure, autoimmune hypoparathyroidism, autoimmune 
pituitary disease, autoimmune infertility (sperm antibody) 
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- Nonendocrine diseases - pernicious anemia, vitiligo, myasthenia gravis, 
Sjogren's syndrome, rheumatoid arthritis, idiopathic thrombocytopenic 
purpura, chronic active hepatitis, primary biliary cirrhosis 
DM is associated with endocrine disorders and in other autoimmune 
polyglandular syndromes (Dănciulescu, 2004), found with a much lower 
frequency. 
Type B insulin resistance syndrome is caused by insulin antireceptor 
antibodies. One third of patients have associated autoimmune diseases as 
lupus erythematosus, autoimmune thyroid disease. Although blood glucose 
levels are elevated secondary to extreme insulin resistance, ketoacidosis is 
not characteristic. Patients may present spontaneous remissions and severe 
hypoglycemia (insulin-like side effects of insulin antireceptor antibodies, 
effects demonstrated in vitro). 
POEMS syndrome include diabetes, primary gonadal failure, sensory 
and motor neuropathy, bone lesions, hyperpigmentation. 
DIDMOAD syndrome is an autosomal recessive disorder which 
includes diabetes insipidus, diabetes mellitus, optic atrophy, deafness. DM is 
usually the first manifestation in children. 
Trisomy 21 (Down syndrome) is relatively frequently associated with 
the presence of type 1 diabetes and thyroiditis. This suggests that 
chromosomal abnormalities influence the autoimmune processes or that 
susceptibility to develop autoimmune disorders may be associated 
chromosomal abnormalities. 
 
METHODS OF INVESTIGATION 
MATERIAL AND METHOD 
INVESTIGATED POPULATION 
The group of children was represented by 83 subjects aged between 
7-17 years. 
All children from the study group had Type 1 diabetes. 
In the studied group, the gender distribution of the children was 5.9/1, 
represented by 71 girls (85.54%) and 12 boys (14.45%). 
The methods of investigation were represented by clinical data - case 
history, current status, imagistic- thyroid ultrasound, biochemical - for 
glycemic balance: fasting blood glucose, glycosylated hemoglobin, 
investigation of the thyroid gland: TSH, FT4, FT3, thyroid antibodies, 
investigation of the adrenal gland: cortisol, 21-hydroxylase antibodies, 
gonadotropins: FSH, LH and appropriate sex hormones (testosterone, 
estradiol), investigation of celiac disease: antitissue transglutaminase 
antibodies, investigation of pernicious anemia: complete blood count with 
mean cell volume and vitamin B12 levels. 
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Determination of plasma glucose was performed by enzyme 
technique with glucosooxidasis. Normal values were taken between 70 - 110 
mg%; diabetes mellitus - values equal or over 126 mg%, impaired glucose 
tolerance - values between 110 - 125 mg% and the OGTT at 2 h between 140 
- 200 mg% and impaired fasting glucose - values between 110 - 125 mg% 
and OGTT at 2 h under 140 mg%.  
Determination of HbA1c was achieved through the DiaStat for 
measuring HbA1c reported to the total HbA.  
To determine the TSH level in plasma, the free fraction of 
triiodotironin (FT3), and the plasma free fraction of thyroxin (FT4) were 
performed a quantitative method ARCHITECT; witch is an immunological 
method, Chemilumnescent Microparticle Immunoassay (CMIA). Normal 
values were following: TSH = 0.465 - 4.68 Miu/ml, FT3 = 3.69 -10.4 pmol/l, 
FT4 = 10 - 28.2 pmol/l.  
To obtain the level of cortisol was performed the technique 
IMMULITE / IMMULITE 1000, an imunometric method, in solid phase, 
competitive, of chemiluminescent, Immuno Chemilumino Enzymometric 
assay (ICEM). It was considered normal: a.m. 5 - 25 microgram/dl.  
FSH level was measured quantitatively by the ARCHITECT method; 
a Chemilumnescent Microparticle Immunoassay. Reference values: 
determined with ARCHITECT test (Table I). 
Table I. The reference values for FSH 
Population field mIU/ml 
Women: 
- Follicular phase 
- Ovulating phase 
- Luteal phase 
- Postmenopausal 
 
3.35 – 21.63 
4.97 – 20.82 
1.11 – 13.99 
2.58 – 150.53 
Men 1.37 – 13.58 
 
LH level was measured quantitatively by the ARCHITECT method; a 
Chemilumnescent Microparticle Immunoassay. Reference values: 
determined with ARCHITECT test (Table II). 
Table II. The reference values for LH 
Population field mIU/ml 
Women: 
- Follicular phase 
- Ovulating phase 
- Luteal phase 
- Postmenopausal 
1.26 – 10.05 
2.57 – 26.53 
18.06 – 90.23 
0.67 – 23.75 
Men 1.09 – 92.45 
 
Testosterone was determinate by ELISA method. The references 
values are depending by age and gender: 
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Adults: 
- men: 0.019 - 0.145 nmol/L; 
- women in fertile period: < 0.014 nmol/L; 
- pills: 0.001 - 0.0069 nmol/L; 
- postmenopausal: 0.0003 - 0.0058 nmol/L. 
Estradiol was determinate by immunochemical with 
electrochemiluminiscent detection method (ECLIA). The references values 
are depending by age and gender, and at women also with the menstrual 
cycle period and pregnancy (Table III).  
Table III. The reference values for estradiol 
Age and gender References values 
(pmol/L) 
Adults – Women •  Follicular phase 
• Ovulating phase 
• Luteal phase 
• Postmenopausal 
– Men 
46.0 - 607 
315 - 1828 
161 - 774 
<18.4 - 201 
28.0 - 156 
Pregnancy (first quarter) 789 – 15781 
Children (1-10 years) • girls 
• boys 
22.0 - 99.1 
<18.4 - 99.1 
 
The immunological parameters were represented by autoimmune 
thyroid markers - antibodies (antiTPO and antiTg antibodies).  
To determine serum levels of antiTPO antibodies it was used the kit 
AxSYM antiTPO, an immunological method (Microparticle Enzyme 
Immunoassay) (MEIA). Normal values:  antiTPO antibodies <35 IU/ml.  
To determine serum levels of antiTg antibodies it was used the kit 
AxSYM antiTg, a MEIA method as well (Microparticle Enzyme 
Immunoassay). Normal values: antiTg antibodies <55 IU/ml.  
To determine 21-hydroxylase (anti 21-OH antibodies) antibodies 
level it was used the radioimunodetermination method combined with a 
technique of imunoprecipitation, based on human 21-OH marked with I 125 
reacting with the antibodies anti 21-OH from the samples test and forming 
immune complexes that precipitated with the solid-phase of protein A. 
Normal range: <1 IU/ml  
Antitissue transglutaminase antibodies were determinate by ELISA 
method.  
References values: IgA, IgG : <10 U/mL: negative;  ≥10 U/mL: positive. 
 Vitamin B12 levels were determinate by immunochemical with 
electrochemiluminiscent detection method (ECLIA). References values: 191 
- 663 pmol/L (for European population). 
Determination of complete blood count was achieved with automatic 
method: electric impedance method. Normal values (for children): 
erythrocytes = 4 - 5.5 mil/mm3, leucocytes = 4500 – 11000 mil/mm3, 
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plateled = 150000 – 450 000/mm3, hematocrit (Ht): 32 – 44 %, hemoglobin 
(Hb): 9.5 – 15.5 g/dl.  
Constants and red cell indices are calculated automatically, 
depending on the values of Hb, Ht and red blood cells (RBC) count. Normal 
values: mean corpuscular volume (MCV) = 80 - 100 fl, mean corpuscular 
hemoglobin concentration (MCHC) = 32 - 36 g Hb/100 ml erythrocytes, 
mean corpuscular hemoglobin (MCH) = 27 - 32 pg.  
Thyroid ultrasound was performed in all cases and allowed us to 
measure thyroid volume, thyroid study and the changes in parenchyma’s 
density.  
An increased density, uniform, characterizes normal thyroid 
parenchyma easily distinguished from the neck muscles that are hypo dens.  
Inflammatory processes and autoimmune pathology appears hypo 
dens.  The scale was assessed as being discreet +, moderate ++ and marked 
+++.  
In the autoimmune thyroid disease the parenchyma of the gland 
appears hypo dens.  
Chronic autoimmune thyroid disorder appears with a hypoecogenity 
of the parenchyma and normal or increased thyroid volume.  
 
STATISTICAL ANALYSIS 
For statistical analysis we used Microsoft Excel and POP Tools from 
Microsoft Office 2003 and EPI 2000 program. To measure the quantitative 
variables were determined average (A) and standard deviation (SD), and to 
assess the gender differences we used the unpaired t test and ANOVA test, 
considering statistically significant a p < 0.05. 
 
RESULTS AND DISCUSSION 
In the case of children group, the main autoimmune endocrine 
associations were the following (Tab.IV).  
Table IV. The prevalence of autoimmune endocrine diseases in children and 
adolescents group with type 1 diabetes 
Asoociated autoimmune endocrine diseases n % 
ACT 49 59.03% 
Graves-Basedow disease 4 4.82% 
ACT + asymptomatic Addison disease 5 6.02% 
 
From the 83 cases of children and adolescents, in 53 cases were 
associated with two autoimmune endocrine disorders, and in 5 cases three 
autoimmune endocrine disorders. Type 1 diabetes was present in all 58 
cases. In 54 cases with type 1 diabetes was associated ACT, and in 4 cases 
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Graves-Basedow disease. In 5 cases with type 1 diabetes and ACT was 
associated asymptomatic Addison's disease. 
Asymptomatic Addison's disease was diagnosed in 5 children by 
dosing 21-OH antibodies in 37 children from the study. From the 5 patients 
with positive titers, 4 were females and 1 male. The titers were between 1 to 
2 IU/ml in 4 patients, only 1 patient presented titers of 2-3 IU/ml. 
In the children and adolescents group of, in all cases of diabetes type 
1/ACT  association, the first immunopathy was DM type 1, followed by 
ACT appearance at a variable period of time (10 cases after 10-15 years, 34 
cases after 6 – 10 years and 10 cases after 1-5 years of development of DM 
type 1) (Figure 1). In the case of association DM type 1/Graves-Basedow 
disease, the latter appeared before type 1 diabetes with 1 year in all 4 cases. 
We don’t have symptomatic cases of Addison's disease in children 
group, but only 5 cases of asymptomatic Addison's disease identifying 
through the presence of specified antibodies.  
Figure 1. Appearence interval of ACT after DM type 1 
The main types of endocrine organo-specific immunopathies 
diagnosed in the studied group of children and adolescents in are shown in 
Tab.V. 
Table V. Organo-specific endocrine immunopathies diagnosed in children and adolescents group 
Endocrine disorder type Children group Female Male 
n % n % n % 
DM type 1 58 69.88 47 81.03 11 18.96 
ACT 54 65.06 47 87.03 7 12.97 
Graves-Basedow disease 4 4.82 4 100 - - 
Asymptomatic Adisson 
dissease 
5 6.02 4 4.82 1 1.2 
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We don’t find  the presence of PAS I in the study group. PAS I called 
also Blizzard syndrome is characterized by immune deficiency in the defense 
against candida albicans, autoimmune endocrinopathies, and optionally 
ectodermal dystrophy (nail, hair, tooth enamel, cornea) (Dankle, 2006). It is 
transmitted autosomal recessive. 
Initially, chronic mucocutaneous candidiasis occurs, rebellious to 
treatment, followed after several years by development of 
hypoparathyroidism and then by DM type 1 (Bal et al, 2002). 
In the case of  association between hypoparathyroidism and type 1 
diabetes, the onset of type 1 diabetes are reported under the age of 10 years, 
being rare after 20 years (Zosin, 1997). 
PAS II was present in 5 cases. Initially PAS II covered PAS II a 
(Smith syndrome) (Addison's disease associated with autoimmune 
thyroiditis) and PAS II b(Carpenter syndrome) (Addison's disease associated 
with type 1 diabetes). It was later revealed the possibility of a triple 
association: adrenal insufficiency, chronic autoimmune thyroiditis and type 1 
diabetes. 
In the case of PAS II onset is usually with adrenal insufficiency 
(ICSR), in time associating DM type 1; there are cases in which the 
diagnosis is performed simultaneously for ICSR and type 1 diabetes or type 
1 diabetes diagnosis can precede their ICSR (Zosin, 1997). 
The prevalence of PAS type II in the study group was 6.02 % (80% 
girls and 20 % boys, p = 0.057, X2 = 3.6). In United States, approximately 14 
– 20 people per million populations are affected by polyglandular 
autoimmune syndrome type II. Observations have revealed, however, that 
the disease is much more prevalent if sub clinical forms are included 
(Bizarro, 2008).  
Regarding the gender, we don’t find significance difference between 
boys and girls, but in United States the female – to – male ratio of 
polyglandular autoimmune syndrome type II is 3 – 4:1 (Bizarro, 2008). 
Normally, the polyglandular autoimmune syndrome type II occurs in the 
third or fourth decade of life.  
 In all cases was a triple association: adrenal insufficiency, chronic 
autoimmune thyroiditis and type 1 diabetes. We don’t have symptomatic 
cases of Addison's disease in children group, but only 5 cases of 
asymptomatic Addison's disease identifying through the presence of 
specified antibodies.  
The most frequently detected PAS was PAS III containing after 
Blizzard's and Neufeld classification, association of autoimmune thyroid 
disease (Hashimoto's chronic thyroiditis, idiopathic myxedema, 
asymptomatic autoimmune thyroiditis, Graves' disease, endocrine 
ophthalmopathy) with: 
European Scientific Journal   February 2014  edition vol.10, No.6  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
420 
- one or more autoimmune diseases - diabetes type 1 - type 3a 
- association with gastric atrophy, pernicious anemia - type 3b 
- association with vitiligo, alopecia, myasthenia gravis - type 3c. 
In the case of PAS III, its worldwide prevalence is not known. It 
turned out that occurs more frequently in women than in men and at middle 
age but can occur at any age. The most common PAS III is the type 3a (DM 
type 1 association with chronic autoimmune thyroiditis). DM type 1 can be 
consecutive or may precede thyroiditis (Zosin, 1997). 
The prevalence of PAS type III in the study group was 59.03 % 
(85.71% girls and 14.29% boys, p < 0.001, X2 = 50), and the type was PAS 
III a (DM type 1 + autoimmune chronic thyroiditis). The medium age was 
14.46 ± 2.4 years.  
In the study group was a net predominance of females.  
       To endocrine immunopathies may be associated with a variable 
incidence no endocrine organo-specific systemic diseases.       
 In our studied group, the patients presented no endocrine organo-
specific autoimmune diseases. They were represented by vitiligo met at 1.2 
% cases and by the decalvant pelada found in 1.2 % of cases. In 1 case was 
associated vitiligo, characterized by skin pigmentation due to autoimmune 
destruction of melanocytes. It occurred before the onset of endocrine 
immunopathies. Decalvant pelada was met in 1 case and also precede the 
onset of autoimmune endocrinopathies. 
The main endocrine and no endocrine immune association in children 
study group are shown in Fig.2. 
Figure 2. Endocrine and nonendocrine immune association in the group of children and 
adolescents with type 1 diabetes 
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The medium interval between onset age of type 1 diabetes and the 
occurrence of ACT was 8.59 ± 3.24 years. 
No case presented the first endocrine immunopathy ACT, followed 
by type 1 diabetes. 
In 4 cases (4.82%) we found the initial presence of Graves-Basedow 
disease, followed by an interval of 1 year by the occurrence of DM type 1. 
All the subjects were girls, with the medium age 16.75 ± 0.5 years.  
 
Conclusion 
We don’t find PAS I in our study group.  
In the children group, PAS type II comprises 3 diseases: adrenal 
insufficiency, chronic autoimmune thyroiditis and type 1 diabetes; we don’t 
find significance difference between girls and boys. Because Addison's 
disease was asymptomatic, identifying through the presence of specified 
antibodies, if we have a children with two or more autoimmune disease, we 
must investigate him for another possible autoimmune disease. 
The most frequent PAS was PAS III, subtype PAS III a (DM type 1 + 
autoimmune chronic thyroiditis), which prevailed in females.  
So, if a child have an autoimmune disease, we must investigate him 
to another autoimmune diseases through determination of specific antibodies 
(frequent this autoimmune diseases are asymptomatic, identify through the 
presence of autoantibodies).  
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